International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

New corporate member

Arcutis new corporate member

IPC is pleased to welcome Arcutis Biotherapeutics, Inc. as a 2022 Bronze Level Corporate Member. Arcutis, based in Westlake Village, CA, is a medical dermatology company founded in 2016 that champions meaningful innovation to solve the most persistent challenges of patients with immune-mediated dermatological diseases and conditions. “We are delighted to welcome Arcutis Biotherapeutics, Inc. to the IPC family, and look forward to partnering with them to improve the care of people with psoriasis worldwide, through education, research and advocacy,” said IPC CEO Christy Langan.

More information about Arcutis can be found at https://www.arcutis.com/.

Categories

Recent Posts

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Mona El-Kalioby, MBBCh, MSc, MD

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.